230. Alveolar hypoventilation syndrome Disease details / Clinical trials / Drug dev / DR info
Clinical trials : 6 / Drugs : 7 - (DrugBank : 4) / Drug target genes : 16 - Drug target pathways : 26
Alveolar hypoventilation syndrome and other diseases between which drug repositioning (DR) might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Score (Drug repositionability)
| ID | Diseases (Sorted by score) | Score |
|---|---|---|
| 230 | Alveolar hypoventilation syndrome | - |
| 13 | Multiple sclerosis/Neuromyelitis optica | 18.000 |
| 86 | Pulmonary arterial hypertension | 16.216 |
| 115 | Hereditary periodic paralysis | 13.000 |
| 154 | Epilepsy with continuous spikes and waves during slow sleep | 13.000 |
| 114 | Non-dystrophic myotonia syndrome | 11.997 |
| 90 | Retinitis pigmentosa | 11.778 |
| 155 | Acquired aphasia with convulsive disorder | 11.008 |
| 225 | Congenital nephrogenic diabetes insipidus | 10.954 |
| 6 | Parkinson disease | 1.485 |